Catalyst
Slingshot members are tracking this event:
Mast Therapeutics (MSTX) Announces Positive Nonclinical Data for Vepoloxamer in an Animal Model of Microembolization-induced Heart Failure
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| MSTX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 11, 2015
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Vepoloxamer, Preclinical, Microembolization-induced Heart Failure
